Authors
Latest:
Federal Government Funds Two-Thirds of Health Care Costs, Study FindsContrary to popular perceptions that health care financing in the US is predominantly private, Americans pay the world
Latest:
Insurance Claims May Model Anti-HER2 Chemo DemandA study including 10 million patients covered by 11 health plans suggested that insurance claims could be used to estimate the number of early-stage breast cancer cases as well as the demand for anti-HER2 drugs.
Latest:
Can Large Doses of Folic Acid Relieve Migraines?Migraine is the third most prevalent illness in the world, affecting 1 billion individuals worldwide.
Latest:
Impact of L-Methylfolate Combination Therapy Among Diabetic Peripheral Neuropathy PatientsPatients with diabetic peripheral neuropathy taking L-methylfolate, pyridoxal-5'-phosphate, and methylcobalamin (MPM) had lower all-cause hospitalization risk and healthcare costs than patients not taking MPM.
Latest:
Claims Data Analysis of Dosing and Cost of TNF AntagonistHigher drug costs may be attributable to either high initial doses or a dose increase.
Latest:
Personalized Therapy: A Note from the Editor-in-Chief of Pharmacy TimesAs pharmacogenomics continues to progress, specialty pharmacists may dominate treatment for certain diseases.
Latest:
Capecitabine and Warfarin Interaction: A Review of Literature and RecommendationsThe capecitabine and warfarin interaction is well documented in the literature and has earned a black box warning because of its potential severity.
Latest:
MRPs Are Both a Blessing and a CurseMandated medical review panels can help health care professionals but hinder patients who file malpractice suits.
Latest:
Impact of Specialty Pharmacy on Treatment Costs for Rheumatoid ArthritisFor patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.
Latest:
Hemostasis and Thrombosis IssuesNews in the world of anticoagulation is presented, including insights on the new guidelines for warfarin.
Latest:
Large-Scale, Community-Based Trial of a Personalized Drug-Related Problem Rectification SystemA controlled trial of a system for rectifying and preventing drug-related problems was conducted to evaluate improvement in the efficiency of resource utilization.
Latest:
Landmark Supreme Court Ruling: State Regulation of PBM Reimbursement RatesSupreme Court ruling clears the way for states to pass laws that protect pharmacies from predatory reimbursement practices by PBMs.
Latest:
340B and the Medicare Cost ReportCertain institutional providers are required to file a Medicare cost report annually to CMS, which uses that information to set prospective payment rates and determine if Medicare overpaid or underpaid a given institution during the submitted fiscal year.
Latest:
Interferon-Based Therapies for Hepatitis C: Utilization, Costs, and OutcomesThis study illustrates the healthcare utilization patterns, direct costs, and sustained virologic response rates associated with interferon-based therapies for hepatitis C patients.
Latest:
Evolutions in Outpatient Cancer CareWithin the last 5 years changes to oncology private practice have led to these clinics aligning themselves with larger entities to maintain their practices.
Latest:
Direct and Indirect Cost Burden of Chronic Hepatitis CAn estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.
Latest:
Addressing Vaccine Hesitancy Among Health Care WorkersAlthough there is no one-size-fits-all approach to promoting vaccine confidence, a conversation is a great starting point.
Latest:
Data Aggregation in Specialty PharmacyThe value of big data in health care is realized when raw data are transformed into insights that drive practice change and decision making.
Latest:
Comparative Effectiveness Research: Is "Synchronicity" a Valid Outcome?Efforts to compare strategies for healthcare delivery must evaluate effectiveness in terms of the outcomes that we care about most.
Latest:
Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia SyndromeWhile fibromyalgia is associated with a small increase in healthcare costs compared with matched controls, chronic opioid use in these patients results in a large increase.
Latest:
Direct and Indirect Cost Burden of Chronic Hepatitis CAn estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.
Latest:
Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid ArthritisMethotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.
Latest:
Ohio-based Healthcare Companies Pay $19.5 Million to Settle False Medicare Claims AllegationsWhistleblower suits arise from claims for reimbursement under Medicare, Medicaid, or TRICARE.
Latest:
Highlighting the Risk of Occupational Exposure to Hazardous Drugs in the Health Care SettingThe health care setting has the largest and most diverse array of agents that are hazardous to humans.
Latest:
Taking Care of Transplant Patients: A Look at ModernHEALTHOnce patients receive their new organs, the specialty pharmacy can help them navigate through lifelong, complex transplant therapy. Here's a look at one such program.
